Previous close | 100.82 |
Open | 0.00 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 0.00 - 0.00 |
52-week range | |
Volume | |
Avg. volume | 82,013 |
Market cap | 176.468B |
Beta (5Y monthly) | 0.67 |
PE ratio (TTM) | 34.02 |
EPS (TTM) | 2.93 |
Earnings date | 17 Oct 2023 - 23 Oct 2023 |
Forward dividend & yield | 2.04 (2.02%) |
Ex-dividend date | 13 Jul 2023 |
1y target est | N/A |
Abbott (ABT) closed at $98.93 in the latest trading session, marking a -1.35% move from the prior day.
Abbott (ABT) is set to commercialize several biosimilar molecules in key emerging markets via an expanded collaboration with mAbxience.
Abbott (ABT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.